Healthcare -
Biotechnology - NASDAQ - US
$ 1.05
2.94 %
$ 57.8 M
Market Cap
-0.59
P/E
PRLD - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities PRLD - Prelude Therapeutics Incorporated
-34.6 M
LAST VALUE
63.76%
2 YEAR CAGR
-130.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR